Y M Yang1, M Geurts1, J B Smilowitz1, E Sterpin2, B P Bednarz1. 1. Department of Medical Physics, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, Wisconsin 53703. 2. Molecular Imaging, Radiotherapy and Oncology, Université catholique de Louvain, Brussels, Belgium 1348.
Abstract
PURPOSE: Several groups are exploring the integration of magnetic resonance (MR) image guidance with radiotherapy to reduce tumor position uncertainty during photon radiotherapy. The therapeutic gain from reducing tumor position uncertainty using intrafraction MR imaging during radiotherapy could be partially offset if the negative effects of magnetic field-induced dose perturbations are not appreciated or accounted for. The authors hypothesize that a more rotationally symmetric modality such as helical tomotherapy will permit a systematic mediation of these dose perturbations. This investigation offers a unique look at the dose perturbations due to homogeneous transverse magnetic field during the delivery of Tomotherapy(®) Treatment System plans under varying degrees of rotational beamlet symmetry. METHODS: The authors accurately reproduced treatment plan beamlet and patient configurations using the Monte Carlo code geant4. This code has a thoroughly benchmarked electromagnetic particle transport physics package well-suited for the radiotherapy energy regime. The three approved clinical treatment plans for this study were for a prostate, head and neck, and lung treatment. The dose heterogeneity index metric was used to quantify the effect of the dose perturbations to the target volumes. RESULTS: The authors demonstrate the ability to reproduce the clinical dose-volume histograms (DVH) to within 4% dose agreement at each DVH point for the target volumes and most planning structures, and therefore, are able to confidently examine the effects of transverse magnetic fields on the plans. The authors investigated field strengths of 0.35, 0.7, 1, 1.5, and 3 T. Changes to the dose heterogeneity index of 0.1% were seen in the prostate and head and neck case, reflecting negligible dose perturbations to the target volumes, a change from 5.5% to 20.1% was observed with the lung case. CONCLUSIONS: This study demonstrated that the effect of external magnetic fields can be mitigated by exploiting a more rotationally symmetric treatment modality.
PURPOSE: Several groups are exploring the integration of magnetic resonance (MR) image guidance with radiotherapy to reduce tumor position uncertainty during photon radiotherapy. The therapeutic gain from reducing tumor position uncertainty using intrafraction MR imaging during radiotherapy could be partially offset if the negative effects of magnetic field-induced dose perturbations are not appreciated or accounted for. The authors hypothesize that a more rotationally symmetric modality such as helical tomotherapy will permit a systematic mediation of these dose perturbations. This investigation offers a unique look at the dose perturbations due to homogeneous transverse magnetic field during the delivery of Tomotherapy(®) Treatment System plans under varying degrees of rotational beamlet symmetry. METHODS: The authors accurately reproduced treatment plan beamlet and patient configurations using the Monte Carlo code geant4. This code has a thoroughly benchmarked electromagnetic particle transport physics package well-suited for the radiotherapy energy regime. The three approved clinical treatment plans for this study were for a prostate, head and neck, and lung treatment. The dose heterogeneity index metric was used to quantify the effect of the dose perturbations to the target volumes. RESULTS: The authors demonstrate the ability to reproduce the clinical dose-volume histograms (DVH) to within 4% dose agreement at each DVH point for the target volumes and most planning structures, and therefore, are able to confidently examine the effects of transverse magnetic fields on the plans. The authors investigated field strengths of 0.35, 0.7, 1, 1.5, and 3 T. Changes to the dose heterogeneity index of 0.1% were seen in the prostate and head and neck case, reflecting negligible dose perturbations to the target volumes, a change from 5.5% to 20.1% was observed with the lung case. CONCLUSIONS: This study demonstrated that the effect of external magnetic fields can be mitigated by exploiting a more rotationally symmetric treatment modality.
Authors: A J E Raaijmakers; B Hårdemark; B W Raaymakers; C P J Raaijmakers; J J W Lagendijk Journal: Phys Med Biol Date: 2007-11-15 Impact factor: 3.609
Authors: Jan J W Lagendijk; Bas W Raaymakers; Alexander J E Raaijmakers; Johan Overweg; Kevin J Brown; Ellen M Kerkhof; Richard W van der Put; Björn Hårdemark; Marco van Vulpen; Uulke A van der Heide Journal: Radiother Oncol Date: 2007-11-26 Impact factor: 6.280
Authors: B G Fallone; B Murray; S Rathee; T Stanescu; S Steciw; S Vidakovic; E Blosser; D Tymofichuk Journal: Med Phys Date: 2009-06 Impact factor: 4.071
Authors: Ellen M Kerkhof; Bas W Raaymakers; Marco van Vulpen; Bernard A Zonnenberg; J L H Ruud Bosch; R Jeroen A van Moorselaar; Jan J W Lagendijk Journal: BJU Int Date: 2011-01 Impact factor: 5.588
Authors: Ashley E Rubinstein; Skylar Gay; Christine B Peterson; Charles V Kingsley; Ramesh C Tailor; Julianne M Pollard-Larkin; Adam D Melancon; David S Followill; Laurence E Court Journal: PLoS One Date: 2018-11-16 Impact factor: 3.240
Authors: Mariska D den Hartogh; Hans C J de Boer; Eline N de Groot-van Breugel; Jochem R N van der Voort van Zyp; Jochem Hes; Uulke A van der Heide; Floris Pos; Karin Haustermans; Tom Depuydt; Robert Jan Smeenk; Martina Kunze-Busch; Bas W Raaymakers; Linda G W Kerkmeijer Journal: Phys Imaging Radiat Oncol Date: 2019-07-15